NSE filing, NSE: BMLL. Summary written from the filing by ALFA Finder's alert engine.
Bio Medica Laboratories Ltd: key numbers
- Share price
- ₹146.10
- Market cap
- ₹183.7 Cr
- Revenue (annual)
- ₹43.09 Cr
- Net profit (annual)
- ₹11.89 Cr
- P/E (TTM)
- 15.4×Sector 46.1×
- Promoter holding
- 67.70%
- FII holding
- 4.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bio Medica Laboratories Ltd
All →Bio Medica Laboratories Other Announcement
Bio Medica Laboratories intimates non-applicability of its Q2 FY27 Corporate Governance Report under SEBI Reg 27(2). The SME-listed company claims exemption under Reg 15(2) of LODR.
Bio Medica Laboratories Annual General Meeting
Bio Medica Laboratories Ltd announced the outcome of its 11th Annual General Meeting, where shareholders approved financial statements, director re-appointment, auditor appointment, and FII investment limits.
Bio Medica Laboratories Annual General Meeting
Bio Medica Laboratories Limited has issued a notice for its 11th Annual General Meeting, scheduled for September 28, 2026, to conduct ordinary and special business.
Bio Medica Laboratories Management Change
Bio Medica Laboratories Limited has appointed M/s. Vishakha Agrawal & Associates as the Secretarial Auditor of the company effective September 2, 2026.
Bio Medica Laboratories Other Announcement
Bio Medica Laboratories Limited has appointed M/s. Vishakha Agrawal & Associates as the Secretarial Auditor of the Company, effective from September 02, 2026.
Bio Medica Laboratories Board Meeting Outcome
Bio Medica Laboratories announced the outcome of its board meeting, approving the 11th AGM notice, book closure dates, and the appointment of a Secretarial Auditor.
Other other announcement announcements
All →Infronics Systems Other Announcement
Infronics Systems appointed R & A Associates as Secretarial Auditor for FY 2026-27. This is a routine statutory appointment with no financial impact.
- Execution
- FY 2026-27
Onix Solar Energy Other Announcement
Onix Solar Energy's monitoring agency reports its rights issue proceeds are fully utilised. The report covers the quarter ended 30 September 2026.
Steamhouse India Other Announcement
Steamhouse India's Reg 32 statement confirms no deviation in IPO fund utilisation from prospectus objects for the quarter ended September 30, 2026. It also discloses a rectified issue-expense figure reallocating Rs 53.5 million to general corporate purposes.
Pine Labs Other Announcement
Pine Labs Limited filed CARE Ratings' Monitoring Agency Report for the quarter ended September 30, 2026, on its IPO proceeds. The report shows no deviation from objects and no major deviations.
Sihora Industries Other Announcement
Sihora Industries reported IPO proceeds utilisation of Rs.983.87 lakh of Rs.1,056 lakh raised, to September 2026. Shareholders approved the object deviation on 17 August 2026.
Titan Company Other Announcement
Titan's employee stock option trust transferred 19,385 shares worth Rs.8.40 Crore to eligible employees after PSU exercise. The off-market transfer was disclosed under PIT Reg 7(2).
- Value
- ₹8.40 Cr